Markov model for characterizing neuropsychologic impairment and Monte Carlo simulation for optimizing efavirenz therapy.
about
An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS PatientsMarkov Mixed Effects Modeling Using Electronic Adherence Monitoring Records Identifies Influential Covariates to HIV Preexposure Prophylaxis.
P2860
Markov model for characterizing neuropsychologic impairment and Monte Carlo simulation for optimizing efavirenz therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Markov model for characterizin ...... optimizing efavirenz therapy.
@en
type
label
Markov model for characterizin ...... optimizing efavirenz therapy.
@en
prefLabel
Markov model for characterizin ...... optimizing efavirenz therapy.
@en
P2860
P356
P1476
Markov model for characterizin ...... r optimizing efavirenz therapy
@en
P2093
Ene I Ette
Jackson K Mukonzo
P2860
P304
P356
10.1002/JCPH.533
P577
2015-06-19T00:00:00Z